Company intelligence / Profile preview

Dominion Cannabinoids

Richmond, Virginia, United States

Ownership: Private
Development stage: Other

Overview

Dominion Cannabinoids is a biotechnology company focused on the research and development of cannabinoid-based therapeutics. The company specializes in the isolation and synthesis of rare cannabinoids and their analogs to address unmet medical needs in pain management, inflammation, and neurological health. By leveraging advanced extraction and purification technologies, Dominion Cannabinoids aims to create standardized, pharmaceutical-grade cannabinoid formulations. Their work primarily involves pre-clinical exploration of the endocannabinoid system to identify novel therapeutic pathways.

Therapeutic areas: ImmunologyNeurology
Modalities: Small moleculeCannabinoids
Industry: Biotech

Beyond the preview

Go deeper on Dominion Cannabinoids.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dominion Cannabinoids.

Explore the full profile